People: Synta Pharmaceuticals Corp (SNTA.OQ)
10 Dec 2013
Dr. Safi R. Bahcall, Ph.D., is President, Chief Executive Officer, Director of Synta Pharmaceuticals Corp. He co-founded Synta with Dr. Lan Bo Chen and has been Chief Executive Officer and a member of Board of Directors since inception in July 2001. Dr. Bahcall has served as President since December 2003. From 1998 to 2001, Dr. Bahcall was a consultant at McKinsey & Company, a management consulting firm, advising investment banks and pharmaceutical companies on strategy, technology, and operations. Dr. Bahcall also co-founded a drug discovery company focused on novel ion channel research in November 2001, which was acquired by Synta in December 2002. He received his B.A. summa cum laude from Harvard University, was awarded his Ph.D. from Stanford University in theoretical physics, and was a Miller postdoctoral research fellow at the University of California, Berkeley.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|